SCHEDULE 13G/A

ORIC Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 68622P109

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• VIKING GLOBAL INVESTORS LP

  Shares: 6,572,700 · Class: 9.2%

• Viking Global Opportunities Parent GP LLC

  Shares: 6,572,700 · Class: 9.2%

• Viking Global Opportunities GP LLC

  Shares: 4,312,800 · Class: 6.1%

• Viking Global Opportunities Portfolio GP LLC

  Shares: 4,312,800 · Class: 6.1%

• Viking Global Opportunities Illiquid Investments Sub-Master LP

  Shares: 4,312,800 · Class: 6.1%

• Viking Global Opportunities Drawdown GP LLC

  Shares: 2,259,900 · Class: 3.2%

• Viking Global Opportunities Drawdown Portfolio GP LLC

  Shares: 2,259,900 · Class: 3.2%

• Viking Global Opportunities Drawdown (Aggregator) LP

  Shares: 2,259,900 · Class: 3.2%

• HALVORSEN OLE ANDREAS

  Shares: 6,572,700 · Class: 9.2%

• Ott David C.

  Shares: 6,572,700 · Class: 9.2%

• Shabet Rose Sharon

  Shares: 6,572,700 · Class: 9.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.